Age-Related microRNA Overexpression in Lafora Disease Male Mice Provides Links between Neuroinflammation and Oxidative Stress
Authors:
- Carlos Romá-MateoCarlos Romá-Mateo
- Sheila Lorente-PozoSLSheila Lorente-Pozo
- Lucía Márquez-ThibautLMLucía Márquez-Thibaut
- Mireia Moreno-EstellésMMMireia Moreno-Estellés
- Concepción GarcésCGConcepción Garcés
- Daymé GonzálezDGDaymé González
- Marcos LahuertaMLMarcos Lahuerta
- Carmen AguadoCACarmen Aguado
- José Luis García-GiménezJGJosé Luis García-Giménez
- Pascual SanzPSPascual Sanz
- Federico V. PallardóFPFederico V. Pallardó
Open Access
- 6 January 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (2) , 1089
Abstract
Lafora disease is a rare, fatal form of progressive myoclonus epilepsy characterized by continuous neurodegeneration with epileptic seizures, characterized by the intracellular accumulation of aberrant polyglucosan granules called Lafora bodies. Several works have provided numerous evidence of molecular and cellular alterations in neural tissue from experimental mouse models deficient in either laforin or malin, two proteins related to the disease. Oxidative stress, alterations in proteostasis, and deregulation of inflammatory signals are some of the molecular alterations underlying this condition in both KO animal models. Lafora bodies appear early in the animal’s life, but many of the aforementioned molecular aberrant processes and the consequent neurological symptoms ensue only as animals age. Here, using small RNA-seq and quantitative PCR on brain extracts from laforin and malin KO male mice of different ages, we show that two different microRNA species, miR-155 and miR-146a, are overexpressed in an age-dependent manner. We also observed altered expression of putative target genes for each of the microRNAs studied in brain extracts. These results open the path for a detailed dissection of the molecular consequences of laforin and malin deficiency in brain tissue, as well as the potential role of miR-155 and miR-146a as specific biomarkers of disease progression in LD.Keywords
Funding Information
- Ministerio de Ciencia e Innovación (PID2020-112972RB-I00, ACCI2020, 202032, P01NS097197, FPU18/03969)
- CIBERER (PID2020-112972RB-I00, ACCI2020, 202032, P01NS097197, FPU18/03969)
- La Fundació la Marato TV3 (PID2020-112972RB-I00, ACCI2020, 202032, P01NS097197, FPU18/03969)
- National Institutes of Health (PID2020-112972RB-I00, ACCI2020, 202032, P01NS097197, FPU18/03969)
- Spanish Ministry of Universities (PID2020-112972RB-I00, ACCI2020, 202032, P01NS097197, FPU18/03969)
This publication has 37 references indexed in Scilit:
- Lafora disease E3 ubiquitin ligase malin is recruited to the processing bodies and regulates the microRNA-mediated gene silencing process via the decapping enzyme Dcp1aRNA Biology, 2012
- Deciphering the role of malin in the lafora progressive myoclonus epilepsyIUBMB Life, 2012
- Malin knockout mice support a primary role of autophagy in the pathogenesis of Lafora diseaseAutophagy, 2012
- Lafora bodies and neurological defects in malin-deficient mice correlate with impaired autophagyHuman Molecular Genetics, 2011
- Impaired autophagy in Lafora diseaseAutophagy, 2010
- Switching from Repression to Activation: MicroRNAs Can Up-Regulate TranslationScience, 2007
- Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivoProceedings of the National Academy of Sciences, 2007
- Laforin, a Dual Specificity Phosphatase That Dephosphorylates Complex CarbohydratesJournal of Biological Chemistry, 2006
- Biochemical studies on tissues from a patient with lafora diseaseClinica Chimica Acta, 1975
- Beitrag zur Histopathologie der myoklonischen EpilepsieZeitschrift für die gesamte Neurologie und Psychiatrie, 1911